Skip to content

Motor Evoked Potentials With Modified Facilitation Technique

Motor Evoked Potentials With Modified Facilitation Technique: Normative Data and Reliability in Healthy Individuals and Comparison of Sensitivity and Specificity With Standard Technique in Patients With Multiple Sclerosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03646929
Acronym
EP-F
Enrollment
81
Registered
2018-08-24
Start date
2017-12-20
Completion date
2019-01-15
Last updated
2021-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

facilitation technique, multimodal evoked potentials (mmEP) in multiple sclerosis, motor evoked potential (MEP) in multiple sclerosis

Brief summary

Investigating the change in Test- Retest- reliability in healthy individuals when applying a modified easy to use facilitation technique compared to standard facilitation technique and analyzing sensitivity and specificity in patients with multiple sclerosis regarding detection of pathologic results

Interventions

DIAGNOSTIC_TESTMEP using standard facilitation technique

measuring of MEP using standard facilitation technique according to the Guidelines of International Federation of Clinical Neurophysiology

DIAGNOSTIC_TESTMEP using modified facilitation technique

measuring of MEP using modified facilitation technique (application of additional 8-12x magnetic stimuli for arms and legs)

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

for healthy individuals: * Ability to understand the purpose and risks of the study, provide signed and dated informed consent * Between 18 and 65 year of age * No neurologic or psychiatric comorbidity requiring continous treatment * No previous damage of central nervous System Inclusion Criteria for patients: * Ability to understand the purpose and risks of the study, provide signed and dated informed consent * Between 18 and 65 year of age * patients with inflammatory diseases of the central nervous system (CNS) or multiple sclerosis appointed for routine MEP diagnostic at the Department of Clinical Neurophysiology, University Hospital Basel

Exclusion criteria

* Contraindication for measuring of motoric evoked potentials (MEP): metal implants (pacemaker, stents); known epilepsy oder previous epileptic fit * Known disease of the peripheral nervous system (polyneuropathy)

Design outcomes

Primary

MeasureTime frameDescription
Change in Test- Re-Test reliability when using modified facilitation technique (compared to standard facilitation technique) in healthy individualsmeasuring time 2 (75 minutes) maximal 1 month later than measuring time 1 (75 minutes)Determination of mean intra-individual difference between measuring time 1 and measuring time 2 and calculation of standard deviation
comparison of sensitivity and specificity of modified facilitation technique and standard facilitation technique in patients with multiple sclerosis1 measuring time (90 minutes)Determination on the basis of the standard values (established in healthy individuals) in how many patients a pathological result with the modified facilitation technique and the standard facilitation technique is present. Using a a cross-tabulation, the sensitivity and specificity of the modified facilitating technique compared to the standard facilitation technique is measured

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026